These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 394733)

  • 21. Intestinal antibodies in rats following exposure to live Vibrio cholerae.
    Cooper GN; McNab CE; Walker PG; Jackson GD
    Aust J Exp Biol Med Sci; 1984 Aug; 62 ( Pt 4)():465-77. PubMed ID: 6517765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and enumeration of immunocytes producing different classes of vibriolysins after primary and secondary immunization with cholera vaccine.
    Kateley JR; Patel C; Friedman H
    J Immunol; 1974 Dec; 113(6):1815-22. PubMed ID: 4610047
    [No Abstract]   [Full Text] [Related]  

  • 23. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
    Cash RA; Music SI; Libonati JP; Craig JP; Pierce NF; Hornick RB
    J Infect Dis; 1974 Oct; 130(4):325-33. PubMed ID: 4443613
    [No Abstract]   [Full Text] [Related]  

  • 24. Spectrum of gut immunologic reactions: selective induction of distinct responses to Vibrio cholerae WO7 and its toxin.
    Walia K; Vohra H; Singh H; Ganguly NK
    Microbiol Immunol; 2000; 44(11):931-40. PubMed ID: 11145274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vibriolytic IgG immunocyte response of mice after primary and secondary immunization with cholera somatic antigens.
    Friedman H
    Immunology; 1975 Aug; 29(2):283-99. PubMed ID: 51000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The suppressive effect of circulating specific antibody on the response to oral immunisation with Vibrio cholerae.
    Horsfall DJ; Brown MA; Rowley D
    Aust J Exp Biol Med Sci; 1979 Jun; 57(3):271-8. PubMed ID: 533481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Suppressive effects of IgE antibody formation of orally administered living and killed Vibrio cholerae cells in mice].
    Komagata Y
    Kansenshogaku Zasshi; 1984 Apr; 58(4):318-26. PubMed ID: 6434656
    [No Abstract]   [Full Text] [Related]  

  • 28. Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation.
    Borde A; Larsson A; Holmgren J; Nygren E
    Eur J Pharm Biopharm; 2011 Nov; 79(3):508-18. PubMed ID: 21757004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against cholera. A bactericidal mechanism on the mucosal surface of the small intestine of mice.
    Knop J; Rowley D
    Aust J Exp Biol Med Sci; 1975 Apr; 53(2):155-65. PubMed ID: 126054
    [No Abstract]   [Full Text] [Related]  

  • 30. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunisation against cholera with a Ty21a-cholera hybrid.
    La Brooy JT; Forrest B; Bartholomeusz C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):143-7. PubMed ID: 3426872
    [No Abstract]   [Full Text] [Related]  

  • 32. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
    García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
    Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolation and biological properties of three classes of rabbit antibody to Vibrio cholerae.
    Steele EJ; Chaicumpa W; Rowley D
    J Infect Dis; 1974 Aug; 130(2):93-103. PubMed ID: 4842331
    [No Abstract]   [Full Text] [Related]  

  • 34. Kinetics of the vibriocidal antibody response to live oral cholera vaccines.
    Wasserman SS; Losonsky GA; Noriega F; Tacket CO; Castañeda E; Levine MM
    Vaccine; 1994 Aug; 12(11):1000-3. PubMed ID: 7975839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies.
    John M; Bridges EA; Miller AO; Calderwood SB; Ryan ET
    Vaccine; 2002 Jun; 20(21-22):2720-6. PubMed ID: 12034098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.
    Wang Z; Lazinski DW; Camilli A
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
    Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
    Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response of the intestinal mucosa to cholera toxoid.
    Pierce NF; Sack RB
    J Infect Dis; 1977 Aug; 136 Suppl():S113-7. PubMed ID: 894085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.